Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
SIB Swiss Institute of Bioinformatics | RCV000627077 | SCV000883241 | uncertain significance | Developmental and epileptic encephalopathy, 63 | 2018-10-15 | criteria provided, single submitter | curation | This variant is interpreted as Uncertain Significance - Insufficient Evidence, for Epileptic encephalopathy, early infantile, 63, autosomal recessive. The following ACMG Tag(s) were applied: PM2 => Absent from controls (or at extremely low frequency if recessive) in Exome Sequencing Project, 1000 Genomes Project, or Exome Aggregation Consortium. |
Labcorp Genetics |
RCV001320840 | SCV001511643 | uncertain significance | not provided | 2021-12-02 | criteria provided, single submitter | clinical testing | This sequence change replaces leucine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 128 of the CPLX1 protein (p.Leu128Met). This variant is present in population databases (rs371709824, gnomAD 0.2%). This missense change has been observed in individual(s) with severe infantile myoclonic epilepsy and intellectual disability (PMID: 28422131). ClinVar contains an entry for this variant (Variation ID: 523650). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Institute of Human Genetics, |
RCV000627077 | SCV002026338 | likely pathogenic | Developmental and epileptic encephalopathy, 63 | 2017-06-25 | criteria provided, single submitter | research | |
OMIM | RCV000627077 | SCV000747887 | pathogenic | Developmental and epileptic encephalopathy, 63 | 2020-11-17 | no assertion criteria provided | literature only |